These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36978032)

  • 1. Deprescribing psychotropic medicines for behaviours that challenge in people with intellectual disabilities: a systematic review.
    Adams D; Hastings RP; Maidment I; Shah C; Langdon PE
    BMC Psychiatry; 2023 Mar; 23(1):202. PubMed ID: 36978032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of psychotropic medications in adults with intellectual disability: a scoping review.
    Costello A; Hudson E; Morrissey S; Sharma D; Kelly D; Doody O
    Ann Med; 2022 Dec; 54(1):2486-2499. PubMed ID: 36120887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UK psychiatrists' experience of rationalising antipsychotics in adults with intellectual disabilities: A qualitative data analysis of free-text questionnaire responses.
    Shoumi Deb S; Limbu B; Nancarrow T; Gerrard D; Shankar R
    J Appl Res Intellect Disabil; 2023 May; 36(3):594-603. PubMed ID: 36808782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of the evidence for deprescribing interventions among older people living with frailty.
    Ibrahim K; Cox NJ; Stevenson JM; Lim S; Fraser SDS; Roberts HC
    BMC Geriatr; 2021 Apr; 21(1):258. PubMed ID: 33865310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for mental health problems in children and adults with severe intellectual disabilities: a systematic review.
    Vereenooghe L; Flynn S; Hastings RP; Adams D; Chauhan U; Cooper SA; Gore N; Hatton C; Hood K; Jahoda A; Langdon PE; McNamara R; Oliver C; Roy A; Totsika V; Waite J
    BMJ Open; 2018 Jun; 8(6):e021911. PubMed ID: 29921688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study.
    Henderson A; Mcskimming P; Kinnear D; McCowan C; McIntosh A; Allan L; Cooper SA
    BMJ Open; 2020 Sep; 10(9):e036862. PubMed ID: 32912946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities: A Cohort Study Using a Large-scale Health Insurance Database].
    Inoue Y; Okumura Y; Fujita J
    Seishin Shinkeigaku Zasshi; 2016; 118(11):823-833. PubMed ID: 30620838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to Deprescribing Psychotropic Medications for Changed Behaviours in Long-Term Care Residents Living with Dementia.
    Harrison SL; Cations M; Jessop T; Hilmer SN; Sawan M; Brodaty H
    Drugs Aging; 2019 Feb; 36(2):125-136. PubMed ID: 30535930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.
    Melton H; Meader N; Dale H; Wright K; Jones-Diette J; Temple M; Shah I; Lovell K; McMillan D; Churchill R; Barbui C; Gilbody S; Coventry P
    Health Technol Assess; 2020 Sep; 24(43):1-312. PubMed ID: 32924926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in people with intellectual disabilities.
    Ali A; Hall I; Blickwedel J; Hassiotis A
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD003406. PubMed ID: 25847633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for a systematic review exploring the psychometric properties of self-report health-related quality of life and subjective wellbeing measures used by adolescents with intellectual disabilities.
    Maguire S; Davison J; McLaughlin M; Simms V
    Syst Rev; 2022 May; 11(1):81. PubMed ID: 35501922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proxy and self-reported Quality of Life in adults with intellectual disabilities: Impact of psychiatric symptoms, problem behaviour, psychotropic medication and unmet needs.
    Koch AD; Vogel A; Becker T; Salize HJ; Voss E; Werner A; Arnold K; Schützwohl M
    Res Dev Disabil; 2015; 45-46():136-46. PubMed ID: 26233765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities.
    Rana F; Gormez A; Varghese S
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009084. PubMed ID: 23633366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.